Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Protoporphyria, Erythropoietic
- Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline
- GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria
- Study of Bitopertin in Participants With EPP or XLP (APOLLO)
- Pharmacokinetics of Afamelanotide in EPP Patients
- INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
- Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP
- Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
- Effect of Oral Cimetidine in the Protoporphyrias
- Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
- Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoetic Protoporphyria or X-Linked Protoporphyria
- Multicentre Phase III Erythropoietic Protoporphyria Study
- Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria
- Oral Iron for Erythropoietic Protoporphyrias
- Phase III Confirmatory Study in Erythropoietic Protoporphyria
- Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
- Sorbent Therapy of the Cutaneous Porphyrias
- Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
- Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
- Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
- Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria